Giuseppe Danilo Norata/LinkedIn
Nov 22, 2025, 10:21
Giuseppe Danilo Norata At the Cardiorisk 2025 Meeting in Alexandria
Giuseppe Danilo Norata, Professor of Pharmacology at University of Milan, posted on LinkedIn:
”I’m grateful to Prof. Ashraf Reda, Atef Elbahry, Adel El Etriby and Hany Ragy for the kind invitation to the Cardiorisk 2025 meeting in Alexandria, Egypt.
It was a pleasure to be part of the European Atherosclerosis Society-EAVA Joint session and of the International Lipid Summit and to engage with colleagues and experts in cardiovascular research, exchange ideas, and discuss emerging trends in the field.”
Keep up with Hemostasis Today.
-
Oct 9, 2026, 11:06Nobles Green: How siRNA Therapy Helps the Body Form Stronger Clots
-
Oct 9, 2026, 10:53Switching From Emicizumab to Denecimig in Hemophilia A – Rare Disease Advisor
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient
-
Oct 9, 2026, 07:21Federico Ravaioli: 40 kPa Spleen Stiffness May Help Avoid Endoscopy in Chronic PVT